isoalantolactone has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, I; Arha, D; Gayen, JR; Gupta, AP; Maurya, R; Rai, AK; Ramakrishna, E; Riyazuddin, M; Sharma, A; Tamrakar, AK | 1 |
1 other study(ies) available for isoalantolactone and Alloxan Diabetes
Article | Year |
---|---|
Isoalantolactone derivative promotes glucose utilization in skeletal muscle cells and increases energy expenditure in db/db mice via activating AMPK-dependent signaling.
Topics: AMP-Activated Protein Kinases; Animals; Cell Membrane; Diabetes Mellitus, Experimental; Energy Metabolism; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Lipid Metabolism; Male; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Protein Transport; Rats; Sesquiterpenes; Signal Transduction; Time Factors | 2018 |